Belite Bio, Inc

US$154.19As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BLTEHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR 80.72%
Div yield —
ROE (22.10%)
Biotechnology
Beta (5Y) (1.19)
PE TTM —
TSR TTM 45.59%
Mkt cap US$6.210B
ROIC (16.01%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$193
25.44%
(91.77%)
Hold 5|7|2|9|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.75
1.73
1.76
1.78
12.84%
6.09%
1.28%
1.36%
Revenue$M
371.6
377.7
387.1
404.6
2.10%
3.61%
2.89%
9.07%
Peers (US$6.210B)
Cap (US$)
PE
6.306B
—
Capital
TTM
5Y
10Y
Leveragex
0.991
0.112
0.104
EBIT/Intx
0.188
0.268
0.293
Own earn%
(24.98)
9.47
(9.70)
Sh yield%
28.90
26.45
25.34
Owners
Insiders/Inst%
11.40
61.76
Short interest%
2.33
SBC / revenue%
4.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
4–9
$1 testx
0.0
Incr. ROIC%
23